openPR Logo
Press release

Cardiac Biomarkers Market Size, Overview, Outlook, Trends, Size 2024-2033

11-21-2024 11:22 AM CET | Health & Medicine

Press release from: The Business research company

Cardiac Biomarkers Market Size

Cardiac Biomarkers Market Size

"The Business Research Company recently released a comprehensive report on the Global Cardiac Biomarkers Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The cardiac biomarkers market size has grown rapidly in recent years. It will grow from $17.22 billion in 2023 to $19.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increased healthcare expenditure, fda approvals and regulatory support, aging population, awareness programs, high sensitivity troponin tests, increasing cardiovascular diseases.

The cardiac biomarkers market size is expected to see rapid growth in the next few years. It will grow to $31.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to rising burden of chronic diseases, growing emphasis on early disease detection, expansion of geriatric population, emerging markets development, focus on biomarker panels. Major trends in the forecast period include patient-centric healthcare models, ai and machine learning applications, digital health integration, technological innovations in biomarker discovery, multi-marker panels, liquid biopsy in cardiovascular medicine.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Market Drivers and Trends:

The rising prevalence of cardiovascular disorders is expected to propel the growth of the cardiac biomarker market going forward. Cardiovascular disorders are diseases that affect the heart and blood vessels and include conditions such as coronary artery disease, heart failure, and stroke. Cardiac biomarkers are released into the bloodstream in response to certain cardiovascular disorders, such as myocardial infarction (heart attack), heart failure, and arrhythmias, that can be measured using laboratory tests, and their levels can provide important diagnostic and prognostic information. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based public agency, coronary artery disease (CAD) was responsible for killing 375,476 people in 2021, and about 1 in 20 adults age 20 and older had CAD. In addition, about 2 in 10 deaths from CAD happen to adults less than 65 years old. Therefore, the rising prevalence of cardiovascular disorders is driving the growth of the cardiac biomarker market.

Technological advancements are a key trend gaining popularity in the cardiac biomarker market. Companies operating in the cardiac biomarker market are adopting new technologies to sustain their position in the market. For instance, in April 2021, Roche Diagnostics, a Switzerland-based healthcare company, introduced five new solutions for two significant cardiac biomarkers, highly sensitive cardiac troponin T (cTnT-hs) and the N-terminal pro-brain natriuretic peptide test (NT-proBNP), using Elecsys technology. These solutions support cardiac risk identification and improve diagnosis and help identify cardiovascular risk, better diagnose patients and support early treatment.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10234&type=smp

Major Key Players of the Market:

bioMerieux Inc.; Bio-Rad Laboratories; F. Hoffmann-La Roche AG; Siemens AG; Thermo Fisher Scientific Inc.; Creative Diagnostics; Randox Laboratories Ltd.; Becton Dickinson and Company; Tosoh Corporation; Life Diagnostics; PerkinElmer Inc.; Quidel Corporation; ACS Biomarker BV; LSI Medience Corp.; BioDot; Alere Inc.; Biosensors International Group; Biosynex SA; CardioGenics Holdings Inc.; Danaher Corporation; Cortez Diagnostics Inc.; DIALAB GmbH; Eurolyser Diagnostica GmbH; Grifols SA; Hologic Inc.; InfraRedx Inc.; Labcorp Corp.; Lepu Medical Technology; Myriad Genetics; Nanosphere Inc.; Biora Therapeutics Inc.; Quest Diagnostics

Cardiac Biomarkers Market 2024 Key Insights:

• The cardiac biomarkers market size will grow to $31.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%.
• Rising Prevalence Of Cardiovascular Disorders Drives Expansion Of Cardiac Biomarker Market
• Key Players Introduce Advanced Solutions In Cardiac Biomarker Market
• North America was the largest region in the cardiac biomarkers market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10234&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"""Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Biomarkers Market Size, Overview, Outlook, Trends, Size 2024-2033 here

News-ID: 3749113 • Views:

More Releases from The Business research company

Synthetic Dye Industry Growth Outlook: 7.6% CAGR and $22.08 Billion by 2029
Synthetic Dye Industry Growth Outlook: 7.6% CAGR and $22.08 Billion by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Long-Term Growth Forecast for the Synthetic Dye Market Size 2025? In the past few years, the synthetic dye market has experienced significant growth. Its size is projected to increase from $15.33 billion in 2024 to $16.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. This
Global Soil Conditioners Market Expansion at 7.1% CAGR, Valued at $8.81 Billion by 2029
Global Soil Conditioners Market Expansion at 7.1% CAGR, Valued at $8.81 Billion …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. What Are the Soil Conditioners Market Size Forecast for 2025? The market size for soil conditioners has experienced significant growth in the past years. The market, which was worth $6.31 billion in 2024, is expected to increase to $6.68 billion in 2025, marking a compound annual growth rate (CAGR) of
Rubber Additives Market on Path to Hit $9.26 Billion by 2029 at 9.4% CAGR
Rubber Additives Market on Path to Hit $9.26 Billion by 2029 at 9.4% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Rubber Additives Market Outlook: What Size And CAGR Are Anticipated By 2025? In recent times, the rubber additives market has witnessed significant growth. The market size is projected to escalate from $6.06 billion in 2024 to $6.48 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. Factors
Future of Printing Inks Market: Size, Share & Forecasts to 2029
Future of Printing Inks Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What Is the Projected Market Size Valuation of the Printing Inks Market by 2025? The market size for printing inks has seen consistent expansion over the last few years. The projections estimate an increase from $36.79 billion in 2024 to $38.15 billion in 2025, indicating a Compound Annual Growth Rate (CAGR)

All 5 Releases


More Releases for Cardiac

Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise. Request
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Monitoring & Cardiac Rhythm Management Devices
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,